Production of nickelized shaped articles
    6.
    发明授权
    Production of nickelized shaped articles 失效
    镍化物品的生产

    公开(公告)号:US5438140A

    公开(公告)日:1995-08-01

    申请号:US211726

    申请日:1994-04-28

    CPC分类号: C25D3/18

    摘要: Nickelized shaped articles are produced by electrodeposition of nickel from aqueous acidic baths containing as essential constituents one or more nickel salts, one or more inorganic acids and one or more brighteners, the brighteners used being cyclic ammonium compounds I ##STR1## where the nitrogen atom is part of a pyridine, quinoline or isoquinoline ring system which can additionally carry one or two C.sub.1 -C.sub.4 -alkyl substituents,R.sup.1 and R.sup.2 are each hydrogen or C.sub.1 -C.sub.4 alkyl,A is a group of the formula --CO--O--R.sup.3, --CO--CH.sub.2 --CO--O--R.sup.3, --O--CO--R.sup.3 or --O--R.sup.3,whereR.sup.3 is C.sub.1 -C.sub.12 -alkyl, C.sub.5 -C.sub.8 -cycloalkyl, C.sub.7 -C.sub.12 -phenylalkyl or phenyl which can be substituted by one or two C.sub.1 -C.sub.4 -alkyl radicals, C.sub.1 -C.sub.4 -alkoxy radicals, halogen atoms, hydroxyl groups, phenyl radicals or C.sub.1 -C.sub.4 alkoxycarbonyl groups, m is from 0 to 10, n is from 1 to 4, p is 0 or 1, and X.sup..crclbar. is an n-valent inorganic or organic anion which promotes water solubility,with the proviso that for p=0 and A=--CO--O--C.sub.1 -C.sub.12 -alkyl m must not be 1, 2 or 3 and under the same conditions R.sup.1 must not be hydrogen when m is 0.

    摘要翻译: PCT No.PCT / EP92 / 02180第 371日期1994年04月28日 102(e)日期1994年4月28日PCT提交1992年9月21日PCT公布。 公开号WO93 / 09275 日期:1993年5月13日。镍铁成型制品是通过从含有酸性浴的电解沉积镍制成的,该酸性浴包含作为必需组分的一种或多种镍盐,一种或多种无机酸和一种或多种增白剂,所用的增白剂是环状铵化合物I IMAGE (I)其中氮原子是可另外携带一个或两个C 1 -C 4烷基取代基的吡啶,喹啉或异喹啉环体系的一部分,R 1和R 2各自为氢或C 1 -C 4烷基,A为 式-CO-O-R3,-CO-CH2-CO-O-R3,-O-CO-R3或-O-R3,其中R3是C1-C12-烷基,C5-C8-环烷基,C7-C12- 可以被一个或两个C 1 -C 4烷基,C 1 -C 4烷氧基,卤原子,羟基,苯基或C 1 -C 4烷氧基羰基取代的苯基烷基或苯基,m为0至10,n为1 至4,p为0或1,并且X( - )是促进水溶性的n价无机或有机阴离子,条件是对于p = 0且A = -CO-O-C 1 -C 12烷基m 麝香 t不为1,2或3,在相同条件下,当m为0时,R1不能为氢。

    Bicyclic amine compound and a process for the preparation thereof
    8.
    发明授权
    Bicyclic amine compound and a process for the preparation thereof 失效
    双环胺化合物及其制备方法

    公开(公告)号:US5059608A

    公开(公告)日:1991-10-22

    申请号:US327813

    申请日:1989-03-23

    摘要: The invention relates to a compound useful as an anticonvulsant, and for treatment of delayed neuronal death, the compound being a bicyclic amine of the formula: ##STR1## wherein R.sup.1 is lower alkyl,R.sup.2 is aryl which may have one or more suitable substituent(s), cyclo(lower)alkyl or heterocyclic group,R.sup.3 is hydrogen, lower alkyl which may have one or more suitable substituent(s), lower alkenyl, or acyl which may have one or more suitable substituent(s),R.sup.4 is hydrogen, lower alkyl, or hydroxy(lower)alkyl,R.sup.5 is hydrogen, lower alkyl, halogen, or protected amino, andn is an integer of 1 or 2, with the proviso that when R.sup.3 is lower alkyl which may have one or more suitable substituent(s), R.sup.2 is cyclo(lower)alkyl or heterocyclic group,or a pharmaceutically acceptable salt thereof.

    摘要翻译: 本发明涉及可用作抗惊厥药并用于治疗延迟性神经元死亡的化合物,该化合物为下式的双环胺:其中R 1为低级烷基,R 2为可具有一个或多个合适取代基的芳基( s),环(低级)烷基或杂环基,R 3是氢,可具有一个或多个合适取代基的低级烷基,可具有一个或多个合适取代基的低级烯基或酰基,R 4是氢 ,低级烷基或羟基(低级)烷基,R 5为氢,低级烷基,卤素或被保护的氨基,n为1或2的整数,条件是当R 3为低级烷基时,其可具有一个或多个合适的 取代基,R2是环(低级)烷基或杂环基,或其药学上可接受的盐。

    Novel propane-1,3-diol derivatives and use
    10.
    发明授权
    Novel propane-1,3-diol derivatives and use 失效
    新型丙-1,3-二醇衍生物和用途

    公开(公告)号:US4945098A

    公开(公告)日:1990-07-31

    申请号:US78525

    申请日:1987-07-10

    摘要: A derivative of 2-methylenepropane-1,3-diol of the general formula I ##STR1## where O--A.sup.1 and O--A.sup.2, which can be the same or different, each represents O, O--C(O), O--C(O)NH, O--C(S)NH or O--C(O)O, R.sup.1 represents an alkyl or alkenyl group of 10-22 carbon atoms, n is an integer from 1 to 11, B.sup.+ represents a quaternary ammonium group, either N.sup.+ R.sup.4 R.sup.5 R.sup.6, or N.sup.+ (Het), where R.sup.4, R.sup.5 and R.sup.6 are similar or different alkyl groups of 1-4 carbon atoms, or two or all of R.sup.4, R.sup.5 and R.sup.6 may be incorporated into a cyclic or bicyclic structure, which may contain additional hetero atoms; X.sup.- means the anion of a pharmceutically acceptable inorganic or organic acid; and R.sup.2 and R.sup.3 are the same or different, and represent hydrogen or alkl groups of 1-4 carbon atoms.The present compounds have been shown to possess a PAF antagonistic effect and an inhibitory effect on the growth of tumor cells, and are thus valuable in the human and veterinary practice as platelet aggregation inhibitors, anti-thrombotic agents, anti-asthmatic agents, anti-allergic agents, anti-inflammatory agents, anti-hypotensive agents, anti-ulcer agents, anti-psoriatic agents, anti-graft rejection agents, anti-conception agents and anti-tumor agents.

    摘要翻译: PCT No.PCT / DK86 / 00128 Sec。 371日期1987年7月10日第 102(e)日期1987年7月10日PCT提交1986年11月20日PCT公布。 公开号WO87 / 03281 日本6月4日,1987.通式I的2-亚甲基丙烷-1,3-二醇的衍生物,其中O-A1和O-A2可以相同或不同,各自表示O,OC (O),OC(O)NH,OC(S)NH或OC(O)O,R 1表示10-22个碳原子的烷基或链烯基,n为1至11的整数,B +表示季铵 基团,N + R4R5R6或N +(Het),其中R4,R5和R6是1-4个碳原子的相似或不同的烷基,或者R4,R5和R6中的两个或全部可以并入环状或双环 结构,其可以含有额外的杂原子; X-表示药物可接受的无机或有机酸的阴离子; R2和R3相同或不同,表示1-4个碳原子的氢或烷基。 本发明化合物已显示具有PAF拮抗作用和对肿瘤细胞生长的抑制作用,因此在人和兽医学实践中作为血小板聚集抑制剂,抗血栓形成剂,抗哮喘药,抗 - 过敏剂,抗炎剂,抗低血压剂,抗溃疡剂,抗牛皮癣剂,抗移植物排斥剂,抗受孕剂和抗肿瘤剂。